Neil Schneiderman Selected Research

Insulin Resistance

1/2022	Sex differences in the association of vital exhaustion with regional fat deposition and subclinical cardiovascular disease risk.
4/2019	Associations of insulin resistance with cognition in individuals without diagnosed diabetes: Results from the Hispanic Community Health Study/Study of Latinos.
1/2017	Sex Differences in Associations of Adiposity Measures and Insulin Resistance in US Hispanic/Latino Youth: The Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).
11/2016	Genetic variation near IRS1 is associated with adiposity and a favorable metabolic profile in U.S. Hispanics/Latinos.
10/2015	Objectively Measured Sedentary Time and Cardiometabolic Biomarkers in US Hispanic/Latino Adults: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
7/2015	Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance.
8/2013	Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome.
1/2009	Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.
2/2006	Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study.
3/2005	Effect of behavioral interventions on insulin sensitivity and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Schneiderman Research Topics

Disease

13	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2020 - 01/2004
12	Hypertension (High Blood Pressure) 12/2022 - 07/2004
10	Insulin Resistance 01/2022 - 03/2005
9	Atherosclerosis 11/2015 - 01/2002
8	Obesity 01/2021 - 02/2006
8	Coronary Disease (Coronary Heart Disease) 01/2020 - 07/2003
8	Acquired Immunodeficiency Syndrome (AIDS) 02/2011 - 03/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2020 - 04/2015
7	Inflammation (Inflammations) 08/2015 - 01/2004
6	Disease Progression 01/2017 - 01/2005
5	Stroke (Strokes) 01/2021 - 07/2014
5	Abdominal Obesity 01/2021 - 01/2016
5	Prostatic Neoplasms (Prostate Cancer) 09/2010 - 02/2004
4	Cognitive Dysfunction 01/2022 - 01/2020
4	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2014
4	Prediabetic State (Prediabetes) 01/2019 - 06/2016
4	Neoplasms (Cancer) 02/2017 - 02/2004
3	Hyperglycemia 01/2021 - 01/2017
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 05/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2009
2	HIV Infections (HIV Infection) 05/2020 - 01/2005
2	Chronic Disease (Chronic Diseases) 01/2020 - 02/2017
2	Wounds and Injuries (Trauma) 10/2019 - 04/2013
2	Diabetes Mellitus 10/2016 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 10/2009
2	Overweight 01/2016 - 08/2008
2	Body Weight (Weight, Body) 06/2013 - 05/2013
2	Infections 10/2009 - 10/2002
2	Myocardial Infarction 07/2009 - 01/2009
1	Chronic Renal Insufficiency 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2022
1	Dementia (Dementias) 01/2022
1	Apnea 01/2022
1	Albuminuria 02/2021
1	Heartburn (Pyrosis) 01/2021
1	Transient Ischemic Attack 01/2021
1	Substance-Related Disorders (Drug Abuse) 05/2020
1	Gender Dysphoria 05/2020
1	Alzheimer Disease (Alzheimer's Disease) 12/2019
1	Hyperinsulinism (Hyperinsulinemia) 04/2019
1	Peripheral Arterial Disease 10/2017
1	Hypotension (Low Blood Pressure) 10/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2017
1	Asthma (Bronchial Asthma) 02/2017
1	Hemochromatosis (Bronze Diabetes) 01/2017
1	Iron Deficiencies 01/2017
1	Left Ventricular Dysfunction 04/2016
1	Weight Loss (Weight Reduction) 01/2016

Drug/Important Bio-Agent (IBA)

25	Polymethyl Methacrylate (Sol)IBA 12/2022 - 11/2014
16	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 01/2009
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2014
8	HDL CholesterolIBA 01/2021 - 07/2014
8	LipidsIBA 10/2016 - 02/2006
4	C-Reactive ProteinIBA 01/2022 - 05/2013
4	Antihypertensive Agents (Antihypertensives)IBA 05/2020 - 06/2014
4	Insulin (Novolin)FDA Link 04/2019 - 03/2005
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 04/2013
4	Hemoglobins (Hemoglobin)IBA 10/2017 - 10/2016
4	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2013 - 01/2003
4	Oxytocin (Pitocin)FDA LinkGeneric 05/2013 - 10/2006
3	CholesterolIBA 01/2022 - 11/2015
3	SodiumIBA 01/2022 - 01/2018
3	PotassiumIBA 01/2022 - 01/2018
3	LDL CholesterolIBA 10/2017 - 02/2014
3	lipoprotein cholesterolIBA 10/2017 - 02/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 12/2012 - 03/2003
3	Pharmaceutical PreparationsIBA 01/2007 - 10/2002
2	CreatinineIBA 02/2021 - 10/2016
2	AlbuminsIBA 02/2021 - 10/2016
2	Hormones (Hormone)IBA 05/2020 - 01/2005
2	Indicators and Reagents (Reagents)IBA 11/2015 - 11/2005
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2015 - 08/2014
2	Biological ProductsIBA 12/2014 - 07/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2013 - 09/2005
2	ORALIT (ORS)IBA 11/2012 - 07/2003
2	Antidepressive Agents (Antidepressants)IBA 07/2004 - 06/2003
1	SolutionsIBA 01/2022
1	Dietary PotassiumIBA 01/2022
1	AcidsIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 10/2017
1	oxidized low density lipoproteinIBA 10/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2017
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 02/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	IronIBA 01/2017
1	Serine Proteases (Serine Protease)IBA 01/2017
1	ABO Blood-Group SystemIBA 01/2017
1	Arylamine N-AcetyltransferaseIBA 01/2017
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2017
1	Fatty Acid DesaturasesIBA 01/2017
1	AcetyltransferasesIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017

Therapy/Procedure

8	Therapeutics 05/2020 - 03/2003
5	Highly Active Antiretroviral Therapy (HAART) 08/2008 - 03/2003
3	Prostatectomy (Retropubic Prostatectomy) 09/2010 - 01/2004
3	Radiotherapy 09/2010 - 01/2004
2	Aftercare (After-Treatment) 09/2010 - 05/2005
1	Dental Care 01/2019
1	Glycemic Control 01/2016